Protara Therapeutics Inc (TARA)

SG&A Expense Growth

4.98%

Quarterly · Period ending:

TARA logo

TARA SG&A Expense Growth

Latest reported4.98%
TARA Quarterly SG&A Growth (QoQ) (0.00% → 4.98%)
High-resolution chart · PNG

TARA sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Protara Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
4.9777%
1.8808%
15.206%
-11.1245%
16.881%
3.3867%
12.9812%
-0.3276%
4.1677%
-11.9528%
3.9714%
-8.3998%
6.6245%
-8.275%
10.9805%
-19.8007%
0.2855%
-9.873%
-7.6889%
-2.433%
5.581%
23.2788%
0.7415%
9.7963%
-32.4009%
1,026.1905%
-49.8194%
184.0684%
-1.8327%
51.1558%
-86.8675%
1.25%
-2.6087%
-3.3613%
20.8122%
-6.1905%
-5.8296%
-8.2305%
4.2918%
-10.728%
5.668%
-5.364%
30.5%
5.8201%
-5.0251%
42.1429%
34.4861%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.